Sonoma Pharmaceuticals, Inc. (SNOA)
NASDAQ: SNOA · Real-Time Price · USD
2.630
+0.080 (3.14%)
Dec 20, 2024, 4:00 PM EST - Market closed
Sonoma Pharmaceuticals Stock Forecast
Stock Price Forecast
There is currently no analyst price target forecast available for SNOA.
Analyst Consensus: n/a
Analyst Ratings
There are currently no analyst ratings available for SNOA.
Recommendation Trends
| Rating | Jun '23 | Jul '23 | Aug '23 | Sep '23 |
|---|---|---|---|---|
| Strong Buy | 0 | 0 | 0 | 0 |
| Buy | 0 | 0 | 0 | 0 |
| Hold | 1 | 1 | 1 | 0 |
| Sell | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 |
| Total | 1 | 1 | 1 | 0 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Ladenburg Thalmann | Ladenburg Thalmann | Strong Buy Initiates $65 | Strong Buy | Initiates | $65 | +2,371.48% | Sep 5, 2023 |
| Maxim Group | Maxim Group | Strong Buy → Hold Downgrades n/a | Strong Buy → Hold | Downgrades | n/a | n/a | Mar 6, 2018 |
| Maxim Group | Maxim Group | Strong Buy Maintains $1,800 → $1,980 | Strong Buy | Maintains | $1,800 → $1,980 | +75,185.17% | Nov 10, 2017 |
Financial Forecast
Revenue This Year
15.78M
from 12.74M
Increased by 23.89%
Revenue Next Year
19.79M
from 15.78M
Increased by 25.45%
EPS This Year
-0.68
from -10.64
EPS Next Year
-1.82
from -0.68
Revenue Forecast
| Revenue | 2025 | 2026 |
|---|---|---|
| High | 16.2M | 20.4M |
| Avg | 15.8M | 19.8M |
| Low | 15.2M | 19.0M |
Revenue Growth
| Revenue Growth | 2025 | 2026 |
|---|---|---|
| High | 27.5% | 29.1% |
| Avg | 23.9% | 25.5% |
| Low | 19.0% | 20.5% |
EPS Forecast
| EPS | 2025 | 2026 |
|---|---|---|
| High | -0.70 | -1.88 |
| Avg | -0.68 | -1.82 |
| Low | -0.66 | -1.75 |
EPS Growth
| EPS Growth | 2025 | 2026 |
|---|---|---|
| High | - | - |
| Avg | - | - |
| Low | - | - |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.